nafronyl has been researched along with Arterial Obstructive Diseases in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (77.42) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 1 (3.23) | 29.6817 |
| 2010's | 1 (3.23) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Baltazard, H; Bourrion, B; Fournier, L; François, M; Hazard, A; Sebbag, P | 1 |
| Melzer, J; Saller, R | 1 |
| Heidrich, H | 2 |
| Amberger, HG; Böhme, H; Diehm, C; Dimroth, H; Heidrich, H; Heinrich, F; Hirche, H; Maass, U; Mörl, H; Müller-Bühl, U | 1 |
| Böhme, H; Heidrich, H; Heinrich, F; Hirche, H; Maass, U; Mörl, H; Rudofsky, G; Trübestein, G | 1 |
| Jung, F; Kiesewetter, H | 1 |
| Weidinger, P | 1 |
| Janka, HU; Mehnert, H; Rinninger, F | 1 |
| Chalmers, TC; Dormandy, JA; Loosemore, TM | 1 |
| Glanddier, G; Guidicelli, H; Mosnier, M; Testart, J | 1 |
| Barradell, LB; Brogden, RN | 1 |
| Comte, S; Lebrun, T; Rolland, N; Sailly, JC | 1 |
| Frisius, H; Heidrich, H; Stockmann, U | 1 |
| Barmeyer, J; Hirche, H; Hoffmann, G; Pohle, W; Schümichen, C | 1 |
| Fichte, K; Heidrich, H; Schirop, T | 1 |
| Becker, HM; Elert, O; Häring, R; Hirche, H; Maurer, PC; Raithel, D; Sperling, M; Stockmann, U; Storz, LW | 1 |
| Errasti, M; Gamain, J; Quiret, JC; Rey, JL | 1 |
| Ratschow, R | 1 |
| Baethke, R; Beyer, KH; Heidrich, VH | 1 |
| Arcuri, P; Ciammaichella, A; Solitro, A | 1 |
| Blume, J; Bulling, B; Gerhards, M; Jung, F; Kiesewetter, H | 1 |
| Coudert, J; Fabry, R; Fellmann, N | 1 |
| Arpaia, MR; Del Guercio, R; Leonardo, G | 2 |
| Heidrich, H; Ranft, J | 1 |
| Abendroth, D; Sunder-Plassmann, L | 1 |
| Horsch, S | 1 |
| Heidrich, H; Lammersen, T; Ranft, J | 1 |
| Debry, G; Mosnier, M; Percebois, G; Pointel, JP; Thomas, C | 1 |
5 review(s) available for nafronyl and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Naftidrofuryl in arterial obstructive disease: A systematic revue of the literature].
Topics: Arterial Occlusive Diseases; Humans; Intermittent Claudication; Mobility Limitation; Nafronyl; Randomized Controlled Trials as Topic; Recovery of Function; Treatment Outcome; Vasodilator Agents | 2020 |
[Clinical studies in peripheral arterial occlusive disease: update from the aspects of a meta-narrative review].
Topics: Arterial Occlusive Diseases; Cilostazol; Complementary Therapies; Humans; Intermittent Claudication; Medicine, Tibetan Traditional; Nafronyl; Pentoxifylline; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Tetrazoles; Triglycerides; Walking | 2013 |
[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
Topics: Ancrod; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiomyopathies; Dextrans; Digitalis Glycosides; Dilatation; Dipyridamole; Exercise Therapy; Gangrene; Hemodilution; Humans; Hypertension; Infusions, Intra-Arterial; Infusions, Parenteral; Intermittent Claudication; Mineralocorticoids; Motivation; Nafronyl; Pentoxifylline; Risk; Streptokinase | 1981 |
A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease.
Topics: Alprostadil; Amputation, Surgical; Ancrod; Arterial Occlusive Diseases; Epoprostenol; Humans; Iloprost; Nafronyl; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Survival Analysis | 1994 |
Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.
Topics: Arterial Occlusive Diseases; Arteries; Half-Life; Humans; Nafronyl; Vasodilator Agents | 1996 |
10 trial(s) available for nafronyl and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; Female; Femoral Artery; Furans; Gait; Humans; Intermittent Claudication; Male; Middle Aged; Nafronyl; Random Allocation; Time Factors | 1984 |
Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
Topics: Adult; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Furans; Humans; Male; Middle Aged; Nafronyl; Placebos; Statistics as Topic | 1984 |
[Thrombocyte function in parenteral naftidrofuryl therapy].
Topics: Aged; Arterial Occlusive Diseases; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Female; Furans; Humans; Infusions, Parenteral; Male; Nafronyl | 1982 |
[Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
Topics: Aged; Aged, 80 and over; Analgesics; Arterial Occlusive Diseases; Double-Blind Method; Female; Humans; Ischemia; Leg; Male; Nafronyl; Placebos; Prospective Studies | 1994 |
[Consequences of obliterating arteriopathy of the legs on the professional activity of patients and external assistance].
Topics: Activities of Daily Living; Aged; Arterial Occlusive Diseases; Double-Blind Method; Female; Humans; Male; Nafronyl; Occupational Health; Socioeconomic Factors; Vasodilator Agents | 1999 |
[Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
Topics: Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; Furans; Humans; Male; Middle Aged; Nafronyl; Placebos; Vasodilator Agents | 1979 |
[Influence of vasoactive substances on blood sugar and serum insulin in normal and diabetic carbohydrate metabolism (author's transl)].
Topics: Actihaemyl; Arterial Occlusive Diseases; Bencyclane; Blood Glucose; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Long-Term Care; Male; Middle Aged; Nafronyl; Pentoxifylline; Vasodilator Agents | 1977 |
[Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
Topics: Arterial Occlusive Diseases; Double-Blind Method; Drug Evaluation; Femoral Artery; Furans; Humans; Intermittent Claudication; Nafronyl | 1979 |
Calf sweat lactate in peripheral arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Biomarkers; Double-Blind Method; Female; Furans; Humans; Ischemia; Lactates; Leg; Male; Middle Aged; Nafronyl; Oxygen; Partial Pressure; Pilocarpine; Reference Values; Sweat | 1989 |
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine | 1985 |
16 other study(ies) available for nafronyl and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Current EMNID survey on peripheral arterial occlusive disease].
Topics: Arterial Occlusive Diseases; Evidence-Based Medicine; Germany; Guideline Adherence; Humans; Intermittent Claudication; Nafronyl; Practice Guidelines as Topic | 2002 |
[Hemorheologic therapy in peripheral arterial occlusive disease].
Topics: Adult; Aged; Arterial Occlusive Diseases; Combined Modality Therapy; Hematocrit; Hemodilution; Humans; Hypertension; Leg; Middle Aged; Nafronyl; Rheology; Risk; Thrombosis | 1984 |
[Functional results of oral dusodril therapy of obliterating arteriopathy of the lower extremities. Comparison of the angiogram, plethysmogram and Doppler ultrasound].
Topics: Angiography; Arterial Occlusive Diseases; Female; Furans; Humans; Leg; Male; Middle Aged; Nafronyl; Plethysmography; Ultrasonography | 1983 |
Longterm pH-measurements in the hind limb of the dog.
Topics: Animals; Arterial Occlusive Diseases; Dextrans; Dogs; Hindlimb; Hydrogen-Ion Concentration; Muscles; Nafronyl | 1976 |
[Status epilepticus and transient disorders of heart conduction induced by too fast intravenous infusion of naftidrofuryl].
Topics: Aged; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Electrocardiography; Electroencephalography; Female; Furans; Humans; Infusions, Parenteral; Leg; Nafronyl; Status Epilepticus | 1978 |
[Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
Topics: Adult; Aged; Arterial Occlusive Diseases; Chronic Disease; Diabetes Complications; Exercise Therapy; Female; Furans; Gait; Humans; Injections, Intravenous; Long-Term Care; Male; Middle Aged; Nafronyl | 1976 |
[Effect of naftidrofuryl on creatinine serum concentration and on PAH/inulin clearance in peripheral arterial occlusive diseases].
Topics: Aminohippuric Acids; Arterial Occlusive Diseases; Creatinine; Furans; Glomerular Filtration Rate; Humans; Injections, Intravenous; Inulin; Kidney; Middle Aged; Nafronyl; Regional Blood Flow; Time Factors | 1975 |
[Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].
Topics: Adolescent; Adult; Aged; Arterial Occlusive Diseases; Drug Evaluation; Furans; Humans; Male; Middle Aged; Nafronyl | 1975 |
Conservative drug therapy and walking exercise in stage IIb peripheral arterial occlusion disease.
Topics: Adult; Aged; Arm; Arterial Occlusive Diseases; Combined Modality Therapy; Female; Furans; Hemodilution; Humans; Hydroxyethyl Starch Derivatives; Ischemia; Leg; Male; Middle Aged; Nafronyl; Physical Exertion; Rheology | 1986 |
A new method for the quantitative assessment of arterial insufficiency of the limbs: cutaneous postischemic hyperemia test by laser Doppler.
Topics: Adult; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Blood Pressure; Female; Humans; Hyperemia; Ischemia; Lasers; Leg; Male; Middle Aged; Nafronyl; Regional Blood Flow; Rheology; Skin; Time Factors | 1987 |
[Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease].
Topics: Administration, Oral; Aged; Arterial Occlusive Diseases; Capillaries; Female; Furans; Humans; Injections, Intravenous; Male; Middle Aged; Nafronyl; Skin | 1988 |
[Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Furans; Humans; Infusions, Intravenous; Leg; Male; Microcirculation; Middle Aged; Nafronyl; Thermography | 1988 |
[Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
Topics: Aged; Arterial Occlusive Diseases; Blood Gas Monitoring, Transcutaneous; Drug Administration Schedule; Female; Furans; Humans; Infusions, Intravenous; Male; Middle Aged; Nafronyl; Random Allocation | 1988 |
Evaluation of the effects of vasoactive drugs on cutaneous microcirculation by laser Doppler velocimetry.
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Humans; Injections, Intra-Arterial; Lasers; Male; Middle Aged; Nafronyl; Skin; Ultrasonography; Vascular Diseases; Vasodilator Agents | 1986 |
[Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Capillaries; Female; Furans; Humans; Leg; Male; Middle Aged; Nafronyl; Oxygen; Partial Pressure; Skin; Vasodilator Agents | 1987 |
tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
Topics: Aged; Arterial Occlusive Diseases; Blood Gas Monitoring, Transcutaneous; Female; Furans; Humans; Lactates; Leg; Male; Middle Aged; Nafronyl; Oxygen; Pyruvates; Regional Blood Flow; Vasodilator Agents | 1986 |